The ability of NKG2D to promote inflammation and the sustained expression of NKG2D ligands observed during tumour progression in certain cancers4 led us to postulate that upon long-lasting injury, transforming cells would benefit from NKG2D-ligand expression in sustaining an inflammatory environment that promotes tumorigenesis. Here, KLRK1 is linked to neoplasm.